Duoflex HPR T


Composition:  Bryonia alba 6X, Cimicifuga racemosa 3X, Colchicum autumnale 3C, Kalmia latifolia 3X, Ledum palustre 30X, Rhus toxicodendron 12X.

Classification: Complex Homeopathic Pain Reliever

Product form: Sublingual oral spray

Trademark: The designation Duoflex HPR ™ is trademarked effective as of Jan. 2000.

Production: The product is produced in a GMP licensed facility according to quality standards defined by the U.S. government for the production of pharmaceuticals. All production is conducted in cleanrooms provided with a downflow of specially filtered air. Entry to the production area is available only through sealed air locks.

Agency inspections: The production facility is routinely inspected on a semi-annual basis by the Food and Drug Branch of the California Depar™ent of Health Services according to a schedule controlled by the agency.

Product sources: Natural botanical ingredients.

Bio-Identification: Potentized extracts of herbs that have been used medicinally for over a hundred years.

Toxicity: All extractions are performed using pharmaceutical grade alcohol and purified water. Duoflex HPR contains no toxic residue, no antibiotics, no synthetic medicines, no bacteria, and no hormones of any kind.

Safety: To the best of our knowledge, no dangerous or unpleasant side effects have ever been reported in relation to any of the ingredients in Duoflex HPR. They are regarded as among the safest preparations known to medical science.

Warnings: While none of the ingredients in Duoflex HPR require warnings, certain warnings are mandated: (1) for conditions which may be indicative of a serious underlying disease and should be evaluated by a doctor, i.e. pain that lasts more than 10 days, symptoms that persist or get worse, or the appearance of new symptoms, and (2) the customary: "Keep this and all medicines out of reach of children." and "If you are pregnant or nursing a baby, seek the advice of a health professional before using this product."

FDA Considerations: All the ingredients in Duoflex HPR are prepared in accordance with The Homeopathic Pharmacopeia of the United States and, as such, are recognized as official medicines under the Federal Food, Drug, and Cosmetic Act. Duoflex HPR is produced by an FDA-registered pharmaceutical firm and is labeled and marketed in accordance with FDA Compliance Policy Guide No. 7132.15. There no restrictions on the sale of Duoflex HPR.



Contact us for more info >